Related Experiment Videos
The value of neoadjuvant therapy in localized prostate cancer
W P Witjes1, G O Oosterhof, H E Schaafsma
1Department of Urology, University Hospital Nijmegen, The Netherlands.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Can biological markers replace cystoscopy? An update.
Current opinion in urology·2001
Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction.
The Journal of urology·2001
Real-World Outcomes of Olaparib in Japanese Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer: Exploratory Analysis of BRCA2 Loss and Microsatellite Instability Status.
International journal of urology : official journal of the Japanese Urological Association·2026
Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery.
International journal of urology : official journal of the Japanese Urological Association·2026
The Four-Bladder Neck Implant Technique on Early Outcomes After Prostatic Urethral Lift: A Japanese Prospective Single-Center Study.
International journal of urology : official journal of the Japanese Urological Association·2026
Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy.
International journal of urology : official journal of the Japanese Urological Association·2026
Cathepsin V (CTSV) Shapes the Epigenetic-Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker.
International journal of urology : official journal of the Japanese Urological Association·2026
Stage-Specific Temporal Trends in Treatment Patterns and Overall Survival in Prostate Cancer: A Multicentre Real-World Cohort Study From KAMU-ON.
International journal of urology : official journal of the Japanese Urological Association·2026
Brain Network Convergence of Abnormal Gray Matter and Functional Activity of Pathological Dissociative Symptoms.
Psychiatry and clinical neurosciences·2026
SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.
Journal of visualized experiments : JoVE·2026